DexCom Inc (DXCM)
139.32
-0.17
(-0.12%)
USD |
NASDAQ |
Mar 28, 13:32
DexCom Price to Book Value: 25.96 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 26.00 |
March 26, 2024 | 26.08 |
March 25, 2024 | 26.11 |
March 22, 2024 | 24.82 |
March 21, 2024 | 24.86 |
March 20, 2024 | 24.70 |
March 19, 2024 | 25.00 |
March 18, 2024 | 25.11 |
March 15, 2024 | 24.31 |
March 14, 2024 | 24.13 |
March 13, 2024 | 24.54 |
March 12, 2024 | 25.23 |
March 11, 2024 | 24.79 |
March 08, 2024 | 25.21 |
March 07, 2024 | 24.83 |
March 06, 2024 | 24.92 |
March 05, 2024 | 22.70 |
March 04, 2024 | 22.79 |
March 01, 2024 | 22.69 |
February 29, 2024 | 21.45 |
February 28, 2024 | 21.29 |
February 27, 2024 | 21.49 |
February 26, 2024 | 21.65 |
February 23, 2024 | 21.67 |
February 22, 2024 | 21.90 |
Date | Value |
---|---|
February 21, 2024 | 21.69 |
February 20, 2024 | 21.97 |
February 16, 2024 | 21.81 |
February 15, 2024 | 21.93 |
February 14, 2024 | 21.76 |
February 13, 2024 | 21.81 |
February 12, 2024 | 22.07 |
February 09, 2024 | 22.45 |
February 08, 2024 | 23.68 |
February 07, 2024 | 23.60 |
February 06, 2024 | 23.28 |
February 05, 2024 | 22.59 |
February 02, 2024 | 22.54 |
February 01, 2024 | 22.85 |
January 31, 2024 | 22.61 |
January 30, 2024 | 22.50 |
January 29, 2024 | 23.15 |
January 26, 2024 | 22.72 |
January 25, 2024 | 23.57 |
January 24, 2024 | 23.74 |
January 23, 2024 | 23.68 |
January 22, 2024 | 24.09 |
January 19, 2024 | 23.72 |
January 18, 2024 | 23.75 |
January 17, 2024 | 23.37 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
12.19
Minimum
Jun 16 2022
42.15
Maximum
May 15 2020
22.08
Average
21.33
Median
Price to Book Value Benchmarks
Abbott Laboratories | 5.092 |
Integer Holdings Corp | 2.569 |
Intuitive Surgical Inc | 10.62 |
Edwards Lifesciences Corp | 8.633 |
Insulet Corp | 16.33 |
Price to Book Value Related Metrics
PE Ratio | 106.35 |
PS Ratio | 16.29 |
PEG Ratio | 1.723 |
Price to Free Cash Flow | 115.25 |
Price | 139.32 |
Earnings Yield | 0.94% |
Market Cap | 53.71B |
PEGY Ratio | 1.723 |
Operating PE Ratio | 98.71 |
Normalized PE Ratio | 106.35 |